In Vivo Detection of Neurofibrillary Tangles by 18 F-MK-6240 PET/MR in Patients With Ischemic Stroke

The risk of developing Alzheimer disease is increased after stroke, and this association may not solely be driven by traditional vascular risk factors. Neuronal death leads to the release of tau proteins, which can become dephosphorylated, rephosphorylated, or hyperphosphorylated in the setting of i...

Full description

Saved in:
Bibliographic Details
Published inNeurology Vol. 100; no. 1; p. e62
Main Authors Michiels, Laura, Thijs, Liselot, Mertens, Nathalie, Sunaert, Stefan, Vandenbulcke, Mathieu, Bormans, Guy, Verheyden, Geert, Koole, Michel, Van Laere, Koen, Lemmens, Robin
Format Journal Article
LanguageEnglish
Published United States 03.01.2023
Subjects
Online AccessGet more information

Cover

Loading…
Abstract The risk of developing Alzheimer disease is increased after stroke, and this association may not solely be driven by traditional vascular risk factors. Neuronal death leads to the release of tau proteins, which can become dephosphorylated, rephosphorylated, or hyperphosphorylated in the setting of ischemia, possibly leading to formation of neurofibrillary tangles (NFT). Therefore, a potential synergistic effect between development of tauopathy and cerebrovascular lesion burden may contribute to cognitive decline after stroke. We explored the spatial and temporal distribution of NFT after ischemic stroke in vivo by using F-MK-6240 PET. We included patients with a first ischemic stroke to undergo longitudinal F-MK-6240 PET/MR within 2-4 weeks and 6 months after stroke. For cross-sectional analyses, we also included age-matched healthy controls. We delineated 5 volumes of interest based on T2 FLAIR and T1 MR data: the ischemic lesion, 3 consecutive peri-ischemic areas, and the remaining ipsilesional hemisphere. We performed region-based voxel-wise partial volume correction on the PET data and calculated standardized uptake value ratios (SUVRs) with the cerebellum as the reference region. We did not quantify PET scans of patients within the first month after stroke (n = 17; median age 73 years [interquartile range {IQR}: 62-82 years]) because the signal intensity was influenced by blood-brain barrier breakdown hampering a reliable data analysis. At 6 months after the event (n = 13; median age 71 years [IQR: 60-79 years]), F-MK-6240 SUVR was increased in the ischemic lesion compared with 20 age-matched healthy controls (median age 71.5 years [IQR: 66-76 years]; ratio = 1.62 ± 0.54; 1-sample test: = 0.0015) and gradually decreased in the surrounding tissue (1-way within-subject analysis of variance [F{1.2, 14.8} = 18.0, = 0.00043]). These findings suggest that NFT may form after ischemic stroke and spread in the peri-ischemic brain parenchyma. Further follow-up is required to gain more insight into the spatial and temporal dynamics of this tauopathy after ischemic stroke.
AbstractList The risk of developing Alzheimer disease is increased after stroke, and this association may not solely be driven by traditional vascular risk factors. Neuronal death leads to the release of tau proteins, which can become dephosphorylated, rephosphorylated, or hyperphosphorylated in the setting of ischemia, possibly leading to formation of neurofibrillary tangles (NFT). Therefore, a potential synergistic effect between development of tauopathy and cerebrovascular lesion burden may contribute to cognitive decline after stroke. We explored the spatial and temporal distribution of NFT after ischemic stroke in vivo by using F-MK-6240 PET. We included patients with a first ischemic stroke to undergo longitudinal F-MK-6240 PET/MR within 2-4 weeks and 6 months after stroke. For cross-sectional analyses, we also included age-matched healthy controls. We delineated 5 volumes of interest based on T2 FLAIR and T1 MR data: the ischemic lesion, 3 consecutive peri-ischemic areas, and the remaining ipsilesional hemisphere. We performed region-based voxel-wise partial volume correction on the PET data and calculated standardized uptake value ratios (SUVRs) with the cerebellum as the reference region. We did not quantify PET scans of patients within the first month after stroke (n = 17; median age 73 years [interquartile range {IQR}: 62-82 years]) because the signal intensity was influenced by blood-brain barrier breakdown hampering a reliable data analysis. At 6 months after the event (n = 13; median age 71 years [IQR: 60-79 years]), F-MK-6240 SUVR was increased in the ischemic lesion compared with 20 age-matched healthy controls (median age 71.5 years [IQR: 66-76 years]; ratio = 1.62 ± 0.54; 1-sample test: = 0.0015) and gradually decreased in the surrounding tissue (1-way within-subject analysis of variance [F{1.2, 14.8} = 18.0, = 0.00043]). These findings suggest that NFT may form after ischemic stroke and spread in the peri-ischemic brain parenchyma. Further follow-up is required to gain more insight into the spatial and temporal dynamics of this tauopathy after ischemic stroke.
Author Thijs, Liselot
Michiels, Laura
Verheyden, Geert
Koole, Michel
Van Laere, Koen
Mertens, Nathalie
Sunaert, Stefan
Vandenbulcke, Mathieu
Bormans, Guy
Lemmens, Robin
Author_xml – sequence: 1
  givenname: Laura
  orcidid: 0000-0002-1208-5334
  surname: Michiels
  fullname: Michiels, Laura
  email: laura.michiels@uzleuven.be
  organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium. laura.michiels@uzleuven.be
– sequence: 2
  givenname: Liselot
  surname: Thijs
  fullname: Thijs, Liselot
  organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium
– sequence: 3
  givenname: Nathalie
  orcidid: 0000-0002-2409-7586
  surname: Mertens
  fullname: Mertens, Nathalie
  organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium
– sequence: 4
  givenname: Stefan
  orcidid: 0000-0002-1177-4680
  surname: Sunaert
  fullname: Sunaert, Stefan
  organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium
– sequence: 5
  givenname: Mathieu
  surname: Vandenbulcke
  fullname: Vandenbulcke, Mathieu
  organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium
– sequence: 6
  givenname: Guy
  orcidid: 0000-0002-0335-7190
  surname: Bormans
  fullname: Bormans, Guy
  organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium
– sequence: 7
  givenname: Geert
  orcidid: 0000-0003-3095-8175
  surname: Verheyden
  fullname: Verheyden, Geert
  organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium
– sequence: 8
  givenname: Michel
  surname: Koole
  fullname: Koole, Michel
  organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium
– sequence: 9
  givenname: Koen
  surname: Van Laere
  fullname: Van Laere, Koen
  organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium
– sequence: 10
  givenname: Robin
  orcidid: 0000-0002-4948-5956
  surname: Lemmens
  fullname: Lemmens, Robin
  organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36302665$$D View this record in MEDLINE/PubMed
BookMark eNo9T21PwjAYbIxGXvQfGPP8gUH7dCvtR4Ogi4BEUfxG2q2V6ujINkz49y7x5b7c5S653PXIaSiDJeSK0QFDhsP1Yjag_0DKeByfkC5LUESC41uH9Or6g9LWGKlz0uGCUxQi6ZI8DfDqv0q4tY3NGl8GKB0s7KEqnTeVLwpdHWGlw3thazBHYBKm0fwhEhhTWE5Ww_kT-ABL3XgbmhrWvtlCWmdbu_MZPDdV-WkvyJnTRW0vf7lPXqaT1fg-mj3epeObWZQxEdMo5ioRI-swyyVTimnllBV5rIyiQhjJ2wg5OimtRqeolLlCjUnSasONxT65_undH8zO5pt95Xft_M3fXfwGFY5VXw
CitedBy_id crossref_primary_10_1002_smll_202409713
crossref_primary_10_1089_neu_2023_0085
crossref_primary_10_3390_cells12232763
crossref_primary_10_1002_acn3_52247
ContentType Journal Article
Copyright 2022 American Academy of Neurology.
Copyright_xml – notice: 2022 American Academy of Neurology.
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1212/WNL.0000000000201344
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1526-632X
ExternalDocumentID 36302665
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.XZ
.Z2
01R
0R~
123
1J1
29N
354
3PY
4Q1
4Q2
4Q3
53G
5RE
5VS
6PF
77Y
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AASXQ
AAWTL
AAXQO
AAYEP
ABBLC
ABIVO
ABJNI
ABOCM
ABVCZ
ACDDN
ACGFS
ACIJW
ACILI
ACLDA
ACOAL
ACWRI
ACXJB
ADGGA
AE6
AEBDS
AENEX
AFDTB
AFEXH
AFUWQ
AGINI
AHOMT
AHQNM
AHVBC
AIJEX
AJCLO
AKCTQ
AKULP
AKWKN
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BOYCO
BQLVK
BYPQX
C45
CGR
CS3
CUY
CVF
DIWNM
DU5
E.X
EBS
ECM
EIF
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
GQDEL
HZ~
IKYAY
IN~
IPNFZ
JF7
KD2
KMI
L-C
L7B
N9A
NPM
N~7
N~B
O9-
OAG
OAH
OBH
ODMTH
OHH
OHYEH
OJAPA
OL1
OLB
OLH
OLU
OLV
OLW
OLY
OLZ
OPX
OVD
OVDNE
OVIDH
OVLEI
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
RHI
RIG
RLZ
RXW
SJN
TEORI
V2I
VVN
W3M
WH7
WOQ
WOW
XSW
XXN
XYM
XYN
YBU
YCJ
YFH
~9M
ID FETCH-LOGICAL-c1640-439567ef2cd81991a9f9e6d49b9066b83ef2232f88ea2f9088d92a255f90b3be2
IngestDate Wed Feb 19 02:25:57 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2022 American Academy of Neurology.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1640-439567ef2cd81991a9f9e6d49b9066b83ef2232f88ea2f9088d92a255f90b3be2
ORCID 0000-0002-2409-7586
0000-0002-1177-4680
0000-0003-3095-8175
0000-0002-4948-5956
0000-0002-0335-7190
0000-0002-1208-5334
PMID 36302665
ParticipantIDs pubmed_primary_36302665
PublicationCentury 2000
PublicationDate 2023-01-03
PublicationDateYYYYMMDD 2023-01-03
PublicationDate_xml – month: 01
  year: 2023
  text: 2023-01-03
  day: 03
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Neurology
PublicationTitleAlternate Neurology
PublicationYear 2023
SSID ssj0015279
Score 2.4099257
Snippet The risk of developing Alzheimer disease is increased after stroke, and this association may not solely be driven by traditional vascular risk factors....
SourceID pubmed
SourceType Index Database
StartPage e62
SubjectTerms Aged
Aged, 80 and over
Alzheimer Disease - pathology
Cross-Sectional Studies
Humans
Ischemic Stroke - pathology
Middle Aged
Neurofibrillary Tangles - pathology
Positron-Emission Tomography
Stroke - pathology
Title In Vivo Detection of Neurofibrillary Tangles by 18 F-MK-6240 PET/MR in Patients With Ischemic Stroke
URI https://www.ncbi.nlm.nih.gov/pubmed/36302665
Volume 100
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELc6kKa9IL6_kR94i8zSJHXsR4Q2rUCmac1gb5Pj2LR8JFPJkMYfwN_Nne1kpRsI6EMU2aob-X45311_d0fIc4tF2rjKmckkZ5k2ApOVY5bHea6xwJly6dHFPt87yl4fT45Hox8rrKWzrnqhv1-ZV_I_UoUxkCtmyf6DZIdFYQDuQb5wBQnD9a9kPG2id4tvLSiNzuje9PPlNpDJDxJenkelaj58Nl_RzhyLaJcVbxiHAzY62Cnhl4tDjHgc-OqqSIbt5tEUPF7HmZ91y_bTL1wht_hqIB6ppAs4X_sc60HLl_PFRz-KDZ3agV1TmCWS5r1m7-bgBgzQmp01KqQQzTpjA25DSCJJXUjCqykT1GjCGU9do_QLPRvHlwDltabxCvmSNodjFTbi_f5bX2XSfcBgSX3FyBUBn35xEk55Ci6l7z3x59m1Gtv91AbZAG8D26dizCf8FzVJchmSLuGBtq96nC2y2S-x5p44M6W8SW4E_4K-9GC5RUamuU02i8CguEPqaUMRM3TADG0tXcMMDZih1TkdCzpghgJmtotDumhojxiKiKE9YqhHzF1ytLtTvtpjodMG0-Auxwys0gnPjU10LZALp6SVhteZrCSYpJVIYQpMbyuEUYlFalwtEwXeKNxXaWWSe-Ra0zbmAaFKxnGtpNbwqsP3xzIbC_BxU50JozPLH5L7fn9OTn05lZN-5x79duYx2bqA2RNy3cL7a56CMdhVz5ysfgJbl1c_
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+Vivo+Detection+of+Neurofibrillary+Tangles+by+18+F-MK-6240+PET%2FMR+in+Patients+With+Ischemic+Stroke&rft.jtitle=Neurology&rft.au=Michiels%2C+Laura&rft.au=Thijs%2C+Liselot&rft.au=Mertens%2C+Nathalie&rft.au=Sunaert%2C+Stefan&rft.date=2023-01-03&rft.eissn=1526-632X&rft.volume=100&rft.issue=1&rft.spage=e62&rft_id=info:doi/10.1212%2FWNL.0000000000201344&rft_id=info%3Apmid%2F36302665&rft_id=info%3Apmid%2F36302665&rft.externalDocID=36302665